ResearcherSecond Military Medical UniversityActive in the last 2 years
Panpan Yang
Matched on ORCID iD 0000-0002-7632-279X; OpenAlex author ID A5004395331. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. Co-author DOI 10.1186/s12885-024-12934-y↗
- Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective as CT? Co-author DOI 10.1186/s40644-023-00528-z↗
- Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens. First author DOI 10.1007/s00261-019-02125-w↗
- Optimized ROI size on ADC measurements of normal pancreas, pancreatic cancer and mass-forming chronic pancreatitis. Co-author DOI 10.18632/oncotarget.18457↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chao Ma · 4 shared papers, 2017–2024 · strength 0.59
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y↗
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z↗
- Paper Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imag… DOI 10.1007/s00261-019-02125-w↗
- Jianping Lu · 3 shared papers, 2020–2024 · strength 0.52
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y↗
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z↗
- Paper Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imag… DOI 10.1007/s00261-019-02125-w↗
- Yun Bian · 3 shared papers, 2020–2024 · strength 0.52
- Paper Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. DOI 10.1186/s12885-024-12934-y↗
- Paper Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective a… DOI 10.1186/s40644-023-00528-z↗
- Paper Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imag… DOI 10.1007/s00261-019-02125-w↗
- Yufei Chen · 2 shared papers, 2023–2024 · strength 0.39
- Chengwei Shao · 2 shared papers, 2023–2024 · strength 0.39
- Luguang Chen · 2 shared papers, 2017–2024 · strength 0.27
- Li Wang · 2 shared papers, 2017–2020 · strength 0.20
- Paper Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imag… DOI 10.1007/s00261-019-02125-w↗
- Paper Optimized ROI size on ADC measurements of normal pancreas, pancreatic cancer and mass-forming chronic pancreatitis. DOI 10.18632/oncotarget.18457↗
- Jun Wang · 1 shared paper, 2023 · strength 0.18
- Jianping Lu · 1 shared paper, 2017 · strength 0.06
- Qiang Hao · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.